$2 million CPRIT award brings top cancer researcher to UT Health San Antonio
Mays Cancer Center Annual Report
As part of a $52 million Cancer Prevention and Research Institute of Texas (CPRIT) grant, The University of Texas Health Science Center at San Antonio received $2 million in funding to bring a top cancer researcher on board in 2024. Maria Falzone, PhD, will join as a full member of UT Health San Antonio’s Mays Cancer Center and the Greehey Children’s Cancer Research Institute. She will also be an assistant professor in the Department of Biochemistry and Structural Biology at UT Health San Antonio.
Falzone will devote her efforts to studying the regulation of phospholipase enzymes, key signaling intermediates and their role in physiology and human diseases, particularly cancer. These enzymes are involved in important signaling pathways and play roles in the regulation of cellular growth and metabolism.
“One of my main research goals is to contribute to an increased understanding of cellular signaling and its dysregulation in cancer. It is my hope that our work can make a small contribution to something that eventually helps people, whether it’s therapeutic development or an increased understanding of the underlying cellular processes,” Falzone said.
